At a glance
- Originator Pfizer
- Class
- Mechanism of Action Adenosine A3 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ischaemic heart disorders
Most Recent Events
- 06 Aug 2009 No development reported - Preclinical for Ischaemic heart disorders in USA (unspecified route)
- 25 Mar 2003 Preclinical trials in Ischaemic heart disorders in USA (unspecified route)